• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清抗体抗幽门螺杆菌 FlaA 与胃癌风险。

Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer.

机构信息

Department of Epidemiology, College of Public Health, Harbin Medical University, Harbin, Heilongjiang Province, China.

出版信息

Helicobacter. 2014 Feb;19(1):9-16. doi: 10.1111/hel.12095. Epub 2013 Oct 14.

DOI:10.1111/hel.12095
PMID:24118166
Abstract

BACKGROUND

Helicobacter pylori (H. pylori) infection is a major risk factor for gastric cancer (GC); however, only a minority of infected individuals develops GC. We aim to assess the association between serostatus of antibody against H. pylori flagellin A (FlaA) and risk of GC and to evaluate the value of serum FlaA antibody as a novel screening biomarker for GC risk.

METHODS

A hospital-based case-control study including 232 cases and 264 controls was conducted. Logistic regression was adopted to analyze the association between the serostatus of FlaA antibody and risk of GC. Serum FlaA antibody was measured by an enzyme-linked immunosorbent assay (ELISA). Receiver operating characteristic (ROC) curve was used to evaluate the screening efficacy and to identify a cutoff point of serum FlaA antibody level.

RESULTS

Helicobacter pylori infection was associated with an increased risk of GC (p = .007). A positive association between serum FlaA antibody and GC risk was observed in overall subjects and H. pylori-positive subjects (OR [95% CI]: 6.8 [4.3-10.7] and 6.9 [3.6-13.4], respectively; p < .001). The seropositivity of FlaA antibody was strongly related to GC risk in a dose-dependent manner (p for trend < .001). The optimal cutoff value (OD) was 0.1403, providing a sensitivity of 74.1% and a specificity of 64.4%. The area under the ROC curve (AUC) was 0.74 in overall subjects and 0.73 in H. pylori-positive subjects, respectively.

CONCLUSIONS

FlaA was an independent risk factor for H. pylori-related GC. Serum FlaA antibody may serve as a novel noninvasive biomarker for early detection of GC.

摘要

背景

幽门螺杆菌(H. pylori)感染是胃癌(GC)的主要危险因素;然而,只有少数感染者会发展为 GC。我们旨在评估抗 H. pylori 鞭毛蛋白 A(FlaA)抗体的血清状态与 GC 风险之间的关联,并评估血清 FlaA 抗体作为 GC 风险新型筛查生物标志物的价值。

方法

进行了一项基于医院的病例对照研究,包括 232 例病例和 264 例对照。采用 logistic 回归分析 FlaA 抗体血清状态与 GC 风险之间的关系。采用酶联免疫吸附试验(ELISA)测定血清 FlaA 抗体。采用受试者工作特征(ROC)曲线评估筛查效果,并确定血清 FlaA 抗体水平的截断值。

结果

H. pylori 感染与 GC 风险增加相关(p=0.007)。在总体人群和 H. pylori 阳性人群中,血清 FlaA 抗体与 GC 风险之间存在正相关关系(OR [95%CI]:6.8 [4.3-10.7] 和 6.9 [3.6-13.4];p<0.001)。FlaA 抗体的血清阳性与 GC 风险呈剂量依赖性相关(p 趋势<0.001)。最佳截断值(OD)为 0.1403,灵敏度为 74.1%,特异性为 64.4%。在总体人群和 H. pylori 阳性人群中,ROC 曲线下面积(AUC)分别为 0.74 和 0.73。

结论

FlaA 是 H. pylori 相关 GC 的独立危险因素。血清 FlaA 抗体可能是 GC 早期检测的新型非侵入性生物标志物。

相似文献

1
Serum antibody against Helicobacter pylori FlaA and risk of gastric cancer.血清抗体抗幽门螺杆菌 FlaA 与胃癌风险。
Helicobacter. 2014 Feb;19(1):9-16. doi: 10.1111/hel.12095. Epub 2013 Oct 14.
2
Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.血清幽门螺杆菌KatA和AhpC抗体作为胃癌的新型生物标志物。
World J Gastroenterol. 2016 Jun 7;22(21):5060-7. doi: 10.3748/wjg.v22.i21.5060.
3
Serum Helicobacter pylori FliD antibody and the risk of gastric cancer.血清幽门螺杆菌FliD抗体与胃癌风险
Oncotarget. 2016 Apr 19;7(16):22397-408. doi: 10.18632/oncotarget.7981.
4
Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.胃癌患者和胃癌高危人群中针对幽门螺杆菌的免疫反应。
Helicobacter. 2013 Feb;18(1):73-82. doi: 10.1111/j.1523-5378.2012.00991.x. Epub 2012 Sep 21.
5
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology.幽门螺杆菌感染与胃癌风险:通过新型多重血清学检测对15种幽门螺杆菌蛋白的评估
Cancer Res. 2009 Aug 1;69(15):6164-70. doi: 10.1158/0008-5472.CAN-09-0596. Epub 2009 Jul 14.
6
[Helicobacter pylori CagA(+) infection in gastric cancer patients].胃癌患者中的幽门螺杆菌CagA(+)感染
Pol Merkur Lekarski. 2002 Sep;13(75):216-20.
7
[Clinical and etiological studies of IgG antibodies to Helicobacter pylori detected by enzyme-linked immunosorbent assay].[酶联免疫吸附测定法检测幽门螺杆菌IgG抗体的临床及病因学研究]
Rinsho Byori. 1995 Apr;43(4):375-80.
8
Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.在幽门螺杆菌感染流行的胃癌低发地区,利用胃蛋白酶原I、胃蛋白酶原II和胃泌素-17水平对胃肠化生和萎缩进行血清学评估。
Trop Gastroenterol. 2011 Oct-Dec;32(4):292-8.
9
Helicobacter pylori-CagA seropositivity and nitrite and ascorbic acid food intake as predictors for gastric cancer.幽门螺杆菌细胞毒素相关基因A血清阳性以及亚硝酸盐和抗坏血酸食物摄入量作为胃癌的预测指标
Eur J Cancer. 2004 Jul;40(11):1752-9. doi: 10.1016/j.ejca.2004.04.025.
10
Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.预测胃蛋白酶原水平看似正常的受试者中幽门螺杆菌感染意外根除病例的胃蛋白酶原水平临界值
Digestion. 2017;95(3):229-236. doi: 10.1159/000469705. Epub 2017 Mar 30.

引用本文的文献

1
The Role of Adhesion in Helicobacter pylori Persistent Colonization.黏附在幽门螺杆菌持续定植中的作用。
Curr Microbiol. 2023 Apr 18;80(5):185. doi: 10.1007/s00284-023-03264-6.
2
Antigenic Determinant of FlaA for Developing Serological Diagnostic Methods in Children.用于开发儿童血清学诊断方法的FlaA抗原决定簇
Pathogens. 2022 Dec 15;11(12):1544. doi: 10.3390/pathogens11121544.
3
Diagnostic approach to -related gastric oncogenesis.与……相关的胃癌发生的诊断方法。 (你提供的原文中“-related”处信息不完整,请补充完整以便准确翻译)
Ann Gastroenterol. 2022 Jul-Aug;35(4):333-344. doi: 10.20524/aog.2022.0725. Epub 2022 Jun 2.
4
Serum Helicobacter pylori KatA and AhpC antibodies as novel biomarkers for gastric cancer.血清幽门螺杆菌KatA和AhpC抗体作为胃癌的新型生物标志物。
World J Gastroenterol. 2016 Jun 7;22(21):5060-7. doi: 10.3748/wjg.v22.i21.5060.
5
Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis.幽门螺杆菌感染:细菌毒力因子与发病机制概述
Biomed J. 2016 Feb;39(1):14-23. doi: 10.1016/j.bj.2015.06.002. Epub 2016 Apr 1.
6
Serum Helicobacter pylori FliD antibody and the risk of gastric cancer.血清幽门螺杆菌FliD抗体与胃癌风险
Oncotarget. 2016 Apr 19;7(16):22397-408. doi: 10.18632/oncotarget.7981.